Envoy Medical Q3 2026 Results: Net Loss of $3.93M, Loss Narrows
For the nine months ended September 30, 2026, Envoy Medical reported a net loss of $14.3 million, an improvement from the $17.2 million loss in the prior year period. The company strengthened its balance sheet through a February 2026 offering, increasing cash to $14.6 million and significantly reducing its stockholders' deficit.
- Key figure
- Net loss $3.93M